Indications & Uses
Haloxa is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
0.05% Halobetasol Propionate: Apply a thin layer of Halobetasol Cream or Ointment to the affected skin once or twice daily, as directed by the physician, and rub in gently and completely. Halobetasol 0.05% is a super-high potency corticosteroid; therefore, treatment should be limited to two weeks, and amounts greater than 50 gm/week should not be used. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Halobetasol should not be used with occlusive dressings.0.01% Halobetasol Propionate: Apply a thin layer of Halobetasol Propionate Lotion to affected areas once daily. Rub in gently. Wash hands after each application, unless Halobetasol Propionate Lotion is for treatment of the hands. This Lotion treatment beyond 8 weeks is not recommended, and the total dosage should not exceed approximately 50 g per week. Discontinue treatment if control is achieved before 8 weeks. Do not use with occlusive dressings unless directed by a physician. This Lotion should not be used on the face, groin, or in the axillae. This Lotion is not for oral, ophthalmic, or intravaginal use.
Side Effects
The following adverse effects have been reported infrequently with topical corticosteroids. These reactions include burning, itching, dryness, folliculitis acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin atrophy, secondary infections, striae and miliaria.
Cautions & Contraindications
Warnings & Precautions
Systemic absorption of topical corticosteroids may cause reversible suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis, along with manifestations of Cushing's syndrome, high blood sugar, and glucose in the urine. Patients using a large dose of a potent topical steroid over a large surface area, or under an occlusive dressing, should be evaluated periodically for signs of HPA axis suppression using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is found, an attempt should be made to withdraw the drug, reduce how often it is applied, or switch to a less potent steroid.
Contraindications
Halobetasol Propionate Cream/Ointment should not be used by patients who are known to be hypersensitive to any of its ingredients.